Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge
Journal of Education Health and Sport December 30, 2023 Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś
Psilocybin, a representative psychedelic, shows a safety profile comparable to standard psychiatric drugs. Positive results on various psychiatric scales are clinically meaningful. Most research focuses on depression, the most common mental illness, but evidence also supports its use for trauma and obsessive-compulsive disorders. The review concludes that psilocybin merits further research, as psychedelic-assisted therapies may offer noteworthy opportunities in standard treatment and could become first-line therapy in some cases, though more data is needed.